Compare BioNTech SE - ADR (BNTX) vs SAP SE (SAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs SAP SE — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while SAP SE trades at $206.93 (market cap $240.81B). The key difference: SAP SE is far larger — about 10.3× BioNTech SE - ADR's market cap, and SAP SE pays a 1.4% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | SAP | |
|---|---|---|
Market Cap | $23.31B | $240.81B |
Sector | Health | Technology |
52-Week High | $119.34 | $280.46 |
52-Week Low | $83.89 | $146.38 |
Enterprise Value | $6.60B | $239.52B |
Dividend Yield | — | 1.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →
